<DOC>
	<DOCNO>NCT01484561</DOCNO>
	<brief_summary>The purpose study explore effect CP-690,550 ( Tofacitinib ) measure kidney function patient active rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>The patient must meet American College Rheumatology ( ACR ) classification criterion diagnosis rheumatoid arthritis satisfy least four seven criterion . The patient must active disease Screening predose Day 1 Period 1 . Patient must inadequate response least one diseasemodifying antirheumatic drug ( DMARD ) , nonbiologic biologic , due ineffectiveness intolerance . Pregnant lactate woman Serious medical condition would make treatment CP690,550 potentially unsafe . A patient history asthma , multiple allergy severe allergy ( eg , anaphylaxis ) substance . In particular , history allergy iodine , povidoneiodine , iohexol iodinate contrast medium .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Phase 1</keyword>
</DOC>